The Matchstick Group was founded in 2011 to focus solely on medical device marketing. We looked at the challenges that medical device companies were facing and decided to build a business that serviced their needs specifically. Focusing solely on the medical device market gives us great insight into our client’s business.
Our clients have trusted us to launch more than 50 brands, spanning the US, LATAM and EMEA markets.
The streamlined, targeted process at our medical device marketing agency has worked for these forward-thinking companies:
Could your brand benefit from a new perspective?
The Matchstick Group is a medical device marketing agency for the 21st century. We provide marketing teams with world-class strategic insights and launch winning brands with the speed and efficiency that matches the pace of innovation.
Get the latest updates from The Matchstick Group! You’ll receive occasional emails from us with tips to improve your medical device marketing program.
Generating leads in the medical device industry is not for the faint of heart. Unlike consumer markets where the path from awareness to purchase can be measured in minutes, medical device sales cycles are long, complex, and
Start a conversation about your medical device marketing strategy.
CALL US NOW: +1 (914) 318 7611
If you’re a medical device marketer, use the form below to get in touch. We’ll get back to you within one business day.
Generating leads in the medical device industry is not for the faint of heart. Unlike consumer markets where the path from awareness to purchase can be measured in minutes, medical device sales cycles are long, complex, and
Selecting the right agency partner is one of the most critical decisions a medical device company can make. Unlike consumer products or even pharma brands, medical devices live at the intersection of complex science, stringent regulations, and
Marketing a medical device isn’t like marketing anything else. The stakes are higher, the regulations are stricter, and the audiences—clinicians, procurement committees, patients—are more complex. Add to that an increasingly competitive medtech landscape, and the pressure on
